A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge
- 12 February 1999
- Vol. 17 (9-10) , 1100-1108
- https://doi.org/10.1016/s0264-410x(98)00327-2
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Recovery of Infectious Human Parainfluenza Virus Type 3 from cDNAVirology, 1997
- Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infantsThe Pediatric Infectious Disease Journal, 1996
- A Live Human Parainfluenza Type 3 Virus Vaccine Is Attenuated and Immunogenic in Healthy Infants and ChildrenThe Journal of Infectious Diseases, 1995
- A Live Attenuated Bovine Parainfluenza Virus Type 3 Vaccine Is Safe, Infectious, Immunogenic, and Phenotypically Stable in Infants and ChildrenThe Journal of Infectious Diseases, 1995
- Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeysVirus Research, 1992
- RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3Virology, 1992
- Human Parainfluenza Virus Induces a Type-Specific Protective Immune ResponseThe Journal of Infectious Diseases, 1990
- Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial virusesVirus Research, 1988
- Evaluation of cold‐adapted adn temperature‐sensitive mutants of parainfluenza virus type 3 in weanling hamstersJournal of Medical Virology, 1984
- Cold adaptation of parainfluenza virus type 3: Induction of three phenotypic markersJournal of Medical Virology, 1982